136 related articles for article (PubMed ID: 33075660)
1. SP94 peptide mediating highly specific and efficacious delivery of polymersomal doxorubicin hydrochloride to hepatocellular carcinoma in vivo.
Zhang J; Wang X; Cheng L; Yuan J; Zhong Z
Colloids Surf B Biointerfaces; 2021 Jan; 197():111399. PubMed ID: 33075660
[TBL] [Abstract][Full Text] [Related]
2. Low-toxicity transferrin-guided polymersomal doxorubicin for potent chemotherapy of orthotopic hepatocellular carcinoma in vivo.
Wei Y; Gu X; Cheng L; Meng F; Storm G; Zhong Z
Acta Biomater; 2019 Jul; 92():196-204. PubMed ID: 31102765
[TBL] [Abstract][Full Text] [Related]
3. EGFR-targeted multifunctional polymersomal doxorubicin induces selective and potent suppression of orthotopic human liver cancer in vivo.
Fang Y; Yang W; Cheng L; Meng F; Zhang J; Zhong Z
Acta Biomater; 2017 Dec; 64():323-333. PubMed ID: 29030307
[TBL] [Abstract][Full Text] [Related]
4. GRP78-targeted ferritin nanocaged ultra-high dose of doxorubicin for hepatocellular carcinoma therapy.
Jiang B; Zhang R; Zhang J; Hou Y; Chen X; Zhou M; Tian X; Hao C; Fan K; Yan X
Theranostics; 2019; 9(8):2167-2182. PubMed ID: 31149036
[TBL] [Abstract][Full Text] [Related]
5. Robust, tumor-homing and redox-sensitive polymersomal doxorubicin: A superior alternative to Doxil and Caelyx?
Zou Y; Meng F; Deng C; Zhong Z
J Control Release; 2016 Oct; 239():149-58. PubMed ID: 27569664
[TBL] [Abstract][Full Text] [Related]
6. GE11-Directed Functional Polymersomal Doxorubicin as an Advanced Alternative to Clinical Liposomal Formulation for Ovarian Cancer Treatment.
Zou Y; Xia Y; Meng F; Zhang J; Zhong Z
Mol Pharm; 2018 Sep; 15(9):3664-3671. PubMed ID: 29570299
[TBL] [Abstract][Full Text] [Related]
7. Targeted chemotherapy for subcutaneous and orthotopic non-small cell lung tumors with cyclic RGD-functionalized and disulfide-crosslinked polymersomal doxorubicin.
Zou Y; Wei J; Xia Y; Meng F; Yuan J; Zhong Z
Signal Transduct Target Ther; 2018; 3():32. PubMed ID: 30564464
[TBL] [Abstract][Full Text] [Related]
8. SP94 Peptide-Functionalized PEG-PLGA Nanoparticle Loading with Cryptotanshinone for Targeting Therapy of Hepatocellular Carcinoma.
Nie X; Liu Y; Li M; Yu X; Yuan W; Huang S; Ren D; Wang Y; Wang Y
AAPS PharmSciTech; 2020 Apr; 21(4):124. PubMed ID: 32342227
[TBL] [Abstract][Full Text] [Related]
9. In Vitro and In Vivo Evaluation of SP94 Modified Liposomes Loaded with N-14NCTDA, a Norcantharimide Derivative for Hepatocellular Carcinoma-Targeting.
Jiang Y; Liu X; Tan X; Hou Y; Sun W; Gou J; Yin T; He H; Zhang Y; Tang X
AAPS PharmSciTech; 2020 Oct; 21(7):277. PubMed ID: 33033942
[TBL] [Abstract][Full Text] [Related]
10. Development of human hepatocellular carcinoma cell-targeted protein cages.
Toita R; Murata M; Tabata S; Abe K; Narahara S; Piao JS; Kang JH; Hashizume M
Bioconjug Chem; 2012 Jul; 23(7):1494-501. PubMed ID: 22621213
[TBL] [Abstract][Full Text] [Related]
11. Polymersome-stabilized doxorubicin-lipiodol emulsions for high-efficacy chemoembolization therapy.
Liu J; Zhang L; Zhao D; Yue S; Sun H; Ni C; Zhong Z
J Control Release; 2022 Oct; 350():122-131. PubMed ID: 35973474
[TBL] [Abstract][Full Text] [Related]
12. Doxorubicin Delivered via ApoE-Directed Reduction-Sensitive Polymersomes Potently Inhibit Orthotopic Human Glioblastoma Xenografts in Nude Mice.
Ouyang J; Jiang Y; Deng C; Zhong Z; Lan Q
Int J Nanomedicine; 2021; 16():4105-4115. PubMed ID: 34163162
[TBL] [Abstract][Full Text] [Related]
13. Integrated platform of oxygen self-enriched nanovesicles: SP94 peptide-directed chemo/sonodynamic therapy for liver cancer.
Zhang W; Han B; Gao C; Liu X; Peng Y; Gong C; Hu D; Wang N; Tang S; Zhang B; Zhao M; Peng H
Eur J Pharm Biopharm; 2022 Oct; 179():206-220. PubMed ID: 36150614
[TBL] [Abstract][Full Text] [Related]
14. Glucose-Regulated Protein 78 Targeting ICG and DOX Loaded Hollow Fe
Jin Y; Cheng Z; Yuan Z; Du Y; Tian J; Shao B
Int J Nanomedicine; 2024; 19():189-208. PubMed ID: 38223882
[TBL] [Abstract][Full Text] [Related]
15. Doxorubicin-loaded Fe
Cheng C; Li C; Zhu X; Han W; Li J; Lv Y
J Biomater Appl; 2019 May; 33(10):1373-1381. PubMed ID: 30880566
[TBL] [Abstract][Full Text] [Related]
16. Investigation of SP94 Peptide as a Specific Probe for Hepatocellular Carcinoma Imaging and Therapy.
Li Y; Hu Y; Xiao J; Liu G; Li X; Zhao Y; Tan H; Shi H; Cheng D
Sci Rep; 2016 Sep; 6():33511. PubMed ID: 27649935
[TBL] [Abstract][Full Text] [Related]
17. Janus nanocarrier-based co-delivery of doxorubicin and berberine weakens chemotherapy-exacerbated hepatocellular carcinoma recurrence.
Zhang F; Jia Y; Zheng X; Shao D; Zhao Y; Wang Z; Dawulieti J; Liu W; Sun M; Sun W; Pan Y; Cui L; Wang Y; He K; Zhang M; Li J; Dong WF; Chen L
Acta Biomater; 2019 Dec; 100():352-364. PubMed ID: 31563690
[TBL] [Abstract][Full Text] [Related]
18.
Diril M; Özdokur KV; Yıldırım Y; Karasulu HY
Pharm Dev Technol; 2023 Dec; 28(10):915-927. PubMed ID: 37921920
[TBL] [Abstract][Full Text] [Related]
19. Hepatocellular carcinoma cell-specific peptide ligand for targeted drug delivery.
Lo A; Lin CT; Wu HC
Mol Cancer Ther; 2008 Mar; 7(3):579-89. PubMed ID: 18347144
[TBL] [Abstract][Full Text] [Related]
20. MiR-101 and doxorubicin codelivered by liposomes suppressing malignant properties of hepatocellular carcinoma.
Xu F; Liao JZ; Xiang GY; Zhao PX; Ye F; Zhao Q; He XX
Cancer Med; 2017 Mar; 6(3):651-661. PubMed ID: 28135055
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
